INDmoney
Parmax Pharma Ltd Q3 FY2025-2026 Results: Summary
Revenue | ₹4.33Cr |
Net Profits | ₹0.73Cr |
Net Profit Margins | -16.86% |
Parmax Pharma Ltd’s revenue fell -31.27% since last year same period to ₹4.33Cr in the Q3 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 70.47% jump in its revenue since last 3-months.
Parmax Pharma Ltd’s net profit fell -87.18% since last year same period to ₹0.73Cr in the Q3 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 64.9% jump in its net profits since last 3-months.
Parmax Pharma Ltd’s net profit margin fell -172.34% since last year same period to -16.86% in the Q3 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 79.41% jumped in its net profit margins since last 3-months.
FAQs
What was the revenue for Parmax Pharma Ltd in Q3 results 2025?
The revenue for Parmax Pharma Ltd in the Q3 results 2025 was ₹4.33Cr.
What was the net profit for Parmax Pharma Ltd in Q3 results 2025?
The net profit for Parmax Pharma Ltd in the Q3 results 2025 was ₹0.73Cr.
What was the net profit margin for Parmax Pharma Ltd in Q3 results 2025?
The net profit margin for Parmax Pharma Ltd in the Q3 results 2025 was -16.86%.
What was the revenue for Parmax Pharma Ltd in Q3 results 2024?
The revenue for Parmax Pharma Ltd in the Q3 results 2024 was ₹6.30Cr.
What was the net profit for Parmax Pharma Ltd in Q3 results 2024?
The net profit for Parmax Pharma Ltd in the Q3 results 2024 was ₹0.39Cr.
What was the net profit margin for Parmax Pharma Ltd in Q3 results 2024?
The net profit margin for Parmax Pharma Ltd in the Q3 results 2024 was -6.19%.
